Go Deep
Summit Therapeutics Inc.
Summit Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 13,025 | -15.8 | 22.27 | 0.03 | 1,701.19 |
| Oct 2026 | 13,396 | -15.4 | 21.69 | 0.03 | 1,640.04 |
| Oct 2026 | 14,708 | -14.0 | 19.65 | 0.03 | 1,478.03 |
| Oct 2026 | 15,022 | -13.6 | 19.16 | 0.03 | 1,436.56 |
| Oct 2026 | 14,828 | -14.2 | 19.46 | 0.03 | 1,459.55 |
| Oct 2026 | 15,424 | -13.2 | 18.53 | 0.03 | 1,385.68 |
| Oct 2026 | 14,667 | -14.0 | 19.72 | 0.03 | 1,476.29 |
| Oct 2026 | 14,248 | -14.5 | 20.38 | 0.03 | 1,525.60 |
| Oct 2026 | 14,450 | -14.3 | 20.05 | 0.03 | 1,497.24 |
| Oct 2026 | 14,676 | -14.0 | 19.69 | 0.03 | 1,467.78 |
| Oct 2026 | 14,740 | -13.9 | 19.59 | 0.03 | 1,466.28 |
Summit Therapeutics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -215,700,000.0 | -189,424,000.0 | -219,172,000.0 | -231,793,000.0 |
| EPS | -0.3 | -0.2 | -0.3 | -0.3 |
Summit Therapeutics Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 705,000.0 | — |
| Net Profit | -1,079,586,000.0 | -221,315,000.0 | -614,928,000.0 | -78,782,000.0 | — |
| EPS | -1.4 | -0.3 | -1.0 | -0.4 | — |
Summit Therapeutics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 751,182,000.0 | 435,560,000.0 | 202,949,000.0 | 664,168,000.0 | — |
| Total Liabilities | 92,322,000.0 | 46,812,000.0 | 125,257,000.0 | 537,514,000.0 | — |
| Total Equity | 658,860,000.0 | 388,748,000.0 | 77,692,000.0 | 126,654,000.0 | — |
Owes vs Owns
Summit Therapeutics Inc. owed $0.16 for every $1 it owned in Jun 2026, down from $0.81 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.16× | 0.12× | 0.11× | 0.62× | 0.81× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Summit Therapeutics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 95.0%Fixed assets (tangible) 2.9%Other assets 1.9%
How it's funded — Dec 2025
Long-term debt 2.3%Payables 2.7%Other liabilities 6.8%Shareholders' equity 87.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 713.4 | 412.3 | 186.2 | 348.6 |
| Receivables | 0.0 | 0.6 | 0.8 | 6.1 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 21.7 | 7.4 | 6.1 | 5.1 |
| Intangible assets | 2.0 | 1.9 | 1.9 | 1.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 14.1 | 13.4 | 7.9 | 302.6 |
| Liabilities & equity | ||||
| Short-term debt | 3.4 | 3.8 | 2.8 | 19.8 |
| Long-term debt | 17.5 | 3.5 | 100.0 | 494.5 |
| Payables | 20.3 | 4.6 | 2.7 | 0.4 |
| Other liabilities | 51.1 | 35.0 | 19.8 | 22.8 |
| Shareholders' equity | 658.9 | 388.7 | 77.7 | 126.7 |
| Net tangible assets | 656.9 | 386.9 | 75.8 | 124.9 |
Summit Therapeutics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -322,930,000.0 | -142,106,000.0 | -76,760,000.0 | -41,582,000.0 | — |
| Investing Activities | -174,310,000.0 | -205,341,000.0 | -587,774,000.0 | -624,000.0 | — |
| Financing Activities | 617,533,000.0 | 381,227,000.0 | 86,513,000.0 | 620,244,000.0 | — |